Shield Therapeutics narrows losses as it advances Feraccru to market
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced a decent improvement in revenue in its preliminary results on Wednesday, to £11.9m from £0.6m.
Read more